Vitamin D3 for Life

Live Enlightened

Physiology

Vitamin D, Muscle Respiration and Mitochondrial Signalling: Full Evidence Review

Previous related pageVitamin D, Muscle Respiration and Mitochondrial Signalling: Study SummaryNext related pageVitamin D, Muscle Respiration and Mitochondrial Signalling: Study Summary
Study at a glance

How were vitamin D signals and energy production in muscle studied?

This review examines vitamin D and mitochondria, structures that help cells produce usable energy. Studies used animals with depleted vitamin D, muscle cells with reduced vitamin D receptors, cells given active vitamin D and a small human trial involving supplements and exercise. These are different tests, not repeated tests of one treatment.

How did low vitamin D or fewer receptors affect muscle energy measurements?

Long-term vitamin D depletion reduced selected oxygen-use measurements in rat muscle. Greatly reducing the receptor also lowered the cells’ oxygen use and estimated energy production in muscle cells grown in the laboratory. However, not every mitochondrial measurement decreased. These findings support a role for vitamin D-related signalling in the tested models, without showing that more vitamin D improves human energy production.

Did every experiment show a helpful effect?

No. One exposure to calcitriol, the active hormone, caused stress-related changes in muscle cells grown in the laboratory and reduced some mitochondrial measurements. Several measurements in whole cells remained unchanged. In the human trial, the main measurement of fats in muscle did not show a clear supplement benefit. An additional finding did not establish that vitamin D and exercise worked better together.

Do these findings show more efficient energy production in people?

Oxygen use is not the same as energy efficiency: more oxygen use does not automatically mean more useful output. Small samples, missing human measurements and differences in compounds, models and timing limit comparison. The cell findings do not show that ordinary supplements harm muscle, and the animal findings do not prove a human benefit. More efficient energy production by mitochondria, greater strength and a useful plan for taking supplements remain unestablished by these studies.

Read the full article below ↓

Vitamin D signalling can influence mitochondrial behaviour, but the available experiments do not support a simple claim that taking more vitamin D makes human mitochondria more efficient. Studies of deficient animals, receptor-depleted muscle cells and calcitriol-treated myotubes answer different questions. A small human trial adds a further distinction between changes in muscle measurements and direct evidence of improved mitochondrial respiration. This review examines those differences before considering the metabolic signals that may connect them. Vitamin D, Muscle Respiration and Mitochondrial Signalling: Study Summary.

Bioenergetics and respiratory efficiency

Mitochondria use the energy released from nutrients to support ATP production. Oxygen consumption provides one way to study this process, but it is not a complete measure of efficiency. A cell can consume more oxygen because it is doing more work, because its mitochondria have greater capacity, or because energy is being dissipated. Demonstrating greater efficiency requires knowing what useful output accompanies that consumption. The wider introduction is Vitamin D and Mitochondrial Function. The broader physiological question belongs to Vitamin D and Energy Regulation; the experiments here primarily address capacity, receptor dependence and responses to particular exposures.

It also matters which form of vitamin D is being investigated. Cholecalciferol, or vitamin D3, is different from 25-hydroxyvitamin D and from calcitriol, the active hormone. Adding calcitriol directly to cells bypasses several processes that regulate exposure in a person. Removing the vitamin D receptor is another intervention altogether. Vitamin D Receptors explains the receptor context, but the presence of that receptor does not guarantee a particular metabolic response to supplementation.

Nutritional depletion and receptor experiments

Salles and colleagues combined several approaches in their 2022 paper. Rats underwent dietary vitamin D depletion for nine months; separate experiments examined muscle-specific receptor deletion in mice and responses in muscle cells. With five rats per group in the respiration experiment, oxygen-consumption rates were approximately 20%, 24% and 30% lower with pyruvate/malate, succinate and ascorbate/TMPD, respectively. These substrate combinations probe different parts of the respiratory machinery. Complex-II and citrate-synthase activities were unchanged, so the findings did not indicate a uniform reduction across all mitochondrial measurements. The experiment supports a functional effect of prolonged depletion in this animal setting, rather than a conclusion based only on receptor expression.

The complementary receptor and cell experiments supported involvement of vitamin D signalling in oxidative capacity and metabolic transcription. However, the different arms cannot be treated as interchangeable demonstrations of one mechanism. Dietary depletion changes an animal’s biological environment over time, whereas a muscle-specific genetic manipulation alters a defined signalling component. Agreement between these approaches supports a relationship while leaving open which effects are direct, which are compensatory, and which depend on the surrounding physiology.

The paper also contained human observations and supplementation data. Those findings must be interpreted according to what was actually measured. Body composition estimated by bioelectrical impedance does not measure mitochondrial oxygen consumption. Nor does a difference in a muscle-related outcome identify the respiratory pathway responsible for it. Total lean-mass change and several mitochondrial DNA or respiratory-complex outcomes were null or borderline, and the cell table for mitochondrial transcription factor A (TFAM) did not support a significant change despite more expansive wording elsewhere. These details prevent the study from establishing a general increase in mitochondrial biogenesis.

Important limitations include unblinded animal and cell work, small numbers of independent cell experiments and limitations in cell-line authentication. Some molecular analyses also relied on nominal significance across many measurements. The human material overlapped with an earlier cohort report and must be counted once. Funding and employment links to Danone were disclosed. These issues do not erase the measured respiratory findings, but they constrain how confidently the package can be extended to people or presented as independently replicated evidence.

What receptor knockdown establishes

Ashcroft and colleagues approached the problem through stable receptor knockdown in C2C12 muscle cells. Receptor abundance was reduced by approximately 95%. Respiration, calculated oxidative ATP production and membrane-potential measures fell in the receptor-depleted cells. The work therefore supports a contribution of the receptor to maintaining bioenergetic function in this model.

Respiratory-chain protein content was not correspondingly reduced. This is useful because it shows why counting selected mitochondrial proteins is not equivalent to measuring mitochondrial performance. A cell may retain those proteins while their functional output changes. Conversely, an increase in a protein marker would not, by itself, demonstrate increased respiration. A modest increase in OPA1, a protein involved in mitochondrial membrane organisation, did not amount to direct visual evidence that the mitochondrial network had changed shape.

The experiment did not test dietary vitamin D replacement in humans. It also lacked a receptor rescue or a second independent knockdown strategy, leaving uncertainty about whether all observed changes were specific to the intended manipulation. Replicate wells are laboratory observations, not separate people. The reported ATP production calculation estimates a rate; it should not be described as a measurement of the cell’s total ATP concentration. These distinctions keep the causal interpretation close to the experiment actually performed.

Together, the Salles and Ashcroft programmes support a role for receptor-related signalling in muscle oxidative capacity. They come from different laboratories, but they are not identical-model replications. Neither establishes that supplementation improves human mitochondrial efficiency. That remaining question matters for Vitamin D and Skeletal Muscle Function, where respiratory capacity is only one contributor to strength, movement and fatigue-related experience.

The human trial and its measurement limits

Thomas and colleagues studied older adults in a thirteen-week factorial trial. Participants received cholecalciferol at 10,000 IU per day on five days each week or placebo. The aerobic-training component consisted of sixty minutes daily for seven consecutive days in the final week, not thirteen weeks of exercise. Fifty people enrolled and forty-six completed the trial; fewer had usable imaging or optical measurements. The primary intramyocellular-to-extramyocellular lipid ratio showed no significant supplement effect (p = 0.121), exercise effect (p = 0.178) or interaction (p = 0.915). A secondary comparison of intramyocellular lipid, adjusted for its baseline value, had p = 0.049. That secondary signal does not overturn the primary result or demonstrate synergy.

The distinction between the primary and secondary findings is essential. A change within a group receiving both exercise and vitamin D does not isolate the effect of vitamin D. Nor does it establish synergy between the interventions. That stronger conclusion requires an appropriate comparison between groups and support for the interaction itself, rather than merely observing improvement in the combined arm.

The optical oxygen-consumption measurements were local measures in living muscle. They were not experiments on isolated mitochondria and did not directly demonstrate increased respiratory efficiency. Small groups, missing measurements and multiple secondary comparisons further limit interpretation. Mild baseline insufficiency also means the findings cannot settle what would happen in every severely deficient population. The trial provides human context and uncertainty, not confirmation of the broader mitochondrial claim.

This is especially relevant to Vitamin D and Metabolic Flexibility. Changes in muscle lipid storage, oxygen use and fuel switching are related concepts, but they are not the same endpoint. It would be misleading to describe a selected lipid change as proof that a person has gained more flexible mitochondrial fuel use. Each conclusion needs a measurement capable of answering that specific question.

Counterevidence from calcitriol-treated myotubes

Raiteri and colleagues tested vitamin D metabolites in differentiated C2C12 myotubes under serum-free conditions. A central exposure was 100 nanomolar calcitriol for twenty-four hours. Calcitriol lowered mitochondrial membrane potential and reduced complex-I-supported respiration when cells were permeabilised. Permeabilisation allows investigators to examine respiratory behaviour under experimentally controlled access to substrates; it changes the setting in which the machinery is tested.

Crucially, intact-cell respiration, ATP-linked respiration and reserve measures were unchanged. The paper therefore does not show a uniform collapse of mitochondrial energy production. Its result is more specific: particular mitochondrial measurements deteriorated under one calcitriol exposure, while several whole-cell respiratory measurements did not. Retaining both sides of that result is necessary to understand the evidence.

This finding does not directly contradict the receptor-knockdown experiment. A cell’s need for a receptor and its response to a particular concentration of hormone are different biological questions. Loss of signalling and high experimental exposure need not produce mirror-image effects. Cholecalciferol and calcifediol also differed from calcitriol in this work. The experiment cannot be converted into a claim that ordinary vitamin D supplements damage human muscle.

Mitochondrial signalling and metabolic regulation

The second question is how mitochondrial changes connect to wider metabolic regulation. Mitochondria participate in signalling as well as energy conversion. Their membrane state, redox environment and interactions with cellular quality-control pathways can influence responses to stress. The selected studies provide two complementary views: changes in metabolic transcription associated with vitamin D status or receptor function, and stress signalling under a defined calcitriol exposure.

In the Salles programme, molecular findings accompanied the physiological and cellular measurements. Such findings can suggest routes by which signalling changes oxidative capacity. They do not prove that any one changed transcript is the necessary mediator of the respiratory outcome. Vitamin D and Gene Expression provides the broader regulatory background, while the study itself supports a more bounded conclusion: transcriptional changes are part of the observed response, rather than a fully resolved chain from receptor to human function.

A convincing mediation claim would require showing that interrupting the proposed intermediate specifically prevents the downstream effect, ideally with a suitable rescue. Correlations between a transcript and a respiratory measurement cannot supply that evidence on their own. Nor should a large set of molecular changes be counted as many independent confirmations. They may be linked consequences of the same experimental perturbation.

Redox signals and the source of stress

Raiteri’s experiments connect calcitriol-associated myotube atrophy to oxidative-stress signalling. Antioxidant and kinase-inhibitor interventions helped interrogate the pathway. Their value lies in going beyond a simple observation that stress markers and atrophy occurred together. However, pharmacological interventions can affect more than one target, so the resulting pathway is supported rather than completely genetically identified.

The results with N-acetylcysteine and a mitochondrial antioxidant differed. It would therefore be inaccurate to say that mitochondrial reactive oxygen species were proved to be the initiating cause of every change. A proposed contribution from NOX2 was inferred rather than directly demonstrated. These distinctions matter to Vitamin D and Oxidative Stress: an observed redox response does not automatically identify its cellular source, and different antioxidant interventions are not interchangeable tests.

The study also reported impaired mitophagy-associated turnover. This connects the energetic and signalling questions because cells need to manage damaged or altered mitochondria as well as produce ATP. Yet the respiratory null findings remain in place. A change in quality control can be biologically important without every oxygen-consumption endpoint changing at the same time. It also does not mean that all forms of vitamin D have the same effect on mitochondrial recycling.

Why these findings should remain separate

The evidence does not justify averaging the studies into a single positive or negative effect. Long-term nutritional depletion in rats, receptor knockdown in cultured cells, direct hormone exposure and a human exercise trial differ in intervention, timescale, tissue state and endpoint. The relevant comparison is what each design can establish, not which direction wins a vote across papers.

For readers moving between blood tests and functional claims, Vitamin D Status vs Vitamin D Effect is a useful distinction. A circulating concentration, receptor abundance, cell-culture dose and measured respiratory response describe different parts of the system. None can substitute automatically for the others. A clinical claim would require direct human evidence with an appropriate comparator and outcomes that actually measure the proposed benefit.

The remaining uncertainty is therefore specific. These studies support receptor-related regulation of preclinical mitochondrial function and demonstrate context-dependent stress responses. They leave unresolved whether a particular supplementation regimen improves mitochondrial efficiency in a defined human population, which pathway would mediate that improvement, and whether it would produce a meaningful functional benefit. The human study does not close those gaps, but neither does its primary null result prove that every possible population would respond identically.

Conclusion

Vitamin D-related signalling influences muscle bioenergetics in experimental systems. Nutritional depletion and receptor reduction can lower oxidative capacity, while a particular calcitriol exposure can produce stress-related changes without altering every respiratory measure. Metabolic transcription and redox signalling offer plausible, partly tested connections between these observations. Human mitochondrial efficiency remains unproved by this evidence. The most informative interpretation keeps the compound, receptor manipulation, model and measured outcome attached to each finding.

Original research

Salles J et al. 2022. Vitamin D status modulates mitochondrial oxidative capacities in skeletal muscle: role in sarcopenia. Communications biology. 5(1): 1288. DOI: 10.1038/s42003-022-04246-3. PMID: 36434267.

Ashcroft SP et al. 2020. The vitamin D receptor regulates mitochondrial function in C2C12 myoblasts. American journal of physiology. Cell physiology. 318(3). DOI: 10.1152/ajpcell.00568.2019. PMID: 31940245.

Thomas DT et al. 2019. Local In Vivo Measures of Muscle Lipid and Oxygen Consumption Change in Response to Combined Vitamin D Repletion and Aerobic Training in Older Adults. Nutrients. 11(4): 930. DOI: 10.3390/nu11040930. PMID: 31027191.

Raiteri T et al. 2021. The Atrophic Effect of 1,25(OH)2 Vitamin D3 (Calcitriol) on C2C12 Myotubes Depends on Oxidative Stress. Antioxidants (Basel, Switzerland). 10(12): 1980. DOI: 10.3390/antiox10121980. PMID: 34943083.

Related reading

Original sources

Source

Vitamin D status modulates mitochondrial oxidative capacities in skeletal muscle: role in sarcopenia

We aimed to examine the effects of vitamin D deficiency and supplementation on whole-body energy expenditure and muscle mitochondrial function in old rats, old mice, and human subjects.

Publication details

Salles J et al. 2022. Vitamin D status modulates mitochondrial oxidative capacities in skeletal muscle: role in sarcopenia. Communications biology. 5(1): 1288. DOI: 10.1038/s42003-022-04246-3. PMID: 36434267.

Read more →